Lyca CR 82.5 mg (Tablet (Controlled Release))
Unit Price: ৳ 15.00 (3 x 10: ৳ 450.00)
Strip Price: ৳ 150.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Delta pharma ltd |
| Also available as |
Title
- Lyca CR 82.5 mg Tablet
Categories
- Medicine
- Neuropathic Pain Relief
- Anticonvulsant
- Anti-Epileptic
- Pain Management
Description
- Lyca CR 82.5 mg Tablet is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury in adults. It is also used as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.
Dimensions
- Tablet Size: 82.5 mg
Color Options
- Off-white
Functions
- Relief from Neuropathic Pain
- Adjunct Therapy for Partial-Onset Seizures
- Anticonvulsant Effects
- Pain Management
Materials
- Pregabalin
Technical Specifications
- Molecular Formula: C8H17NO2
Design Elements
- Extended-Release Tablet
- Swallow Whole
- Not to be Split, Crushed, or Chewed
Usability Features
- Oral Administration
- Taken with or without food
- Administered after an evening meal
- Gradual Tapering for Discontinuation
Dosage
- Maximum Recommended Dose: 100 mg three times a day
- Recommended Dose for Postherpetic Neuralgia: 75 to 150 mg two times a day or 50 to 100 mg three times a day
- Recommended Dose for Fibromyalgia: 300 to 450 mg/day
- Recommended Starting Dose for Neuropathic Pain Associated with Spinal Cord Injury: 75 mg two times a day
Drug Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
Contraindications
- Hypersensitivity to Pregabalin or any of its components
Side Effects
- Dizziness
- Somnolence
- Dry Mouth
- Edema
- Blurred Vision
- Weight Gain
- Difficulty with Concentration/Attention
- Increased Weight
- Increased Appetite
Pregnancy & Lactation
- Potential risk to a fetus
- Breastfeeding not recommended
Precautions & Warnings
- Risk of Angioedema
- Discontinuation in case of hypersensitivity reactions
- Increased risk of suicidal thoughts or behavior
- Respiratory depression may occur
- Dizziness and somnolence potential
- Peripheral edema caution
Use in Special Populations
- Safety and effectiveness not established in pediatric patients for certain indications
- Safety and effectiveness in pediatric patients below the age of 1 month not established
Overdose Effects
- General supportive care indicated
- No specific antidote
- Signs and symptoms of reduced consciousness, depression/anxiety, agitation and restlessness, seizures, and heart block
Therapeutic Class
- Adjunct Anti-Epileptic Drugs
- Primary Anti-Epileptic Drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Structural Derivative of the Inhibitory Neurotransmitter Gamma-Aminobutyric Acid (GABA)
- Binds with high affinity to the alpha2-delta site
- Involvement in anti-nociceptive and antiseizure effects
Commonly Asked Questions
- First-line of treatment for neuropathic pain, shingles, seizures, and fibromyalgia
- Prescribed dosage and duration
- Usage post-meal
- Instructions for storage and disposal
- Differential effects for different diseases
Interaction
- Lyca CR is unlikely to be involved in significant pharmacokinetic drug interactions
Drug Interaction with Food
- Not Applicable
Pediatric Uses
- Use in Special Populations such as Children and Adolescents
Drug Classes
- Adjunct Anti-Epileptic Drugs
- Primary Anti-Epileptic Drugs